Related Experiment Video
Updated: Aug 13, 2026

Analysis of Cell Cycle Position in Mammalian Cells
Published on: January 21, 2012
RB and hbrm cooperate to repress the activation functions of E2F1
D Trouche1, C Le Chalony, C Muchardt
1Wellcome/Cancer Research Campaign Institute and Department of Pathology, University of Cambridge, Tennis Court Road, Cambridge CB2 1QR, United Kingdom.
Abstract:
Forced expression of the retinoblastoma (RB) gene product inhibits the proliferation of cells in culture. A major target of the RB protein is the S-phase-inducing transcription factor E2F1. RB binds directly to the activation domain of E2F1 and silences it, thereby preventing cells from entering S phase. To induce complete G1 arrest, RB requires the presence of the hbrm/BRG-1 proteins, which are components of the coactivator SWI/SNF complex. This cooperation is mediated through a physical interaction between RB and hbrm/BRG-1. We show here that in transfected cells RB can contact both E2F1 and hbrm at the same time, thereby targeting hbrm to E2F1. E2F1 and hbrm are indeed found within the same complex in vivo. Furthermore, RB and hbrm cooperate to repress E2F1 activity in transient transfection assays. The ability of hbrm to cooperate with RB to repress E2F1 is dependent upon several distinct domains of hbrm, including the RB binding domain and the NTP binding site. However, the bromodomain seems dispensable for this activity. Taken together, our results point out an unexpected role of corepressor for the hbrm protein. The ability of hbrm and RB to cooperate in repressing E2F1 activity could be an underlying mechanism for the observed cooperation between hbrm and RB to induce G1 arrest. Finally, we demonstrate that the domain of hbrm that binds RB has transcriptional activation potential which RB can repress. This suggest that RB not only targets hbrm but also regulates its activity.
Insights
The retinoblastoma (RB) protein and hbrm/BRG-1 cooperate to inhibit cell proliferation by repressing E2F1 activity. RB targets hbrm to E2F1, revealing hbrm
Area of Science:
- Cell cycle regulation
- Molecular biology
- Transcriptional regulation
Background:
- The retinoblastoma (RB) gene product is a key inhibitor of cell proliferation.
- RB targets the S-phase transcription factor E2F1, silencing its activity to prevent cell cycle entry.
- RB requires hbrm/BRG-1 proteins, part of the SWI/SNF complex, for complete G1 arrest.
Purpose of the Study:
- To investigate the mechanism of cooperation between RB and hbrm/BRG-1 in cell cycle regulation.
- To determine how RB targets hbrm/BRG-1 to E2F1.
- To elucidate the role of specific hbrm/BRG-1 domains in repressing E2F1 activity.
Main Methods:
- Co-immunoprecipitation to detect protein complexes in vivo.
- Transient transfection assays to assess transcriptional repression.
- Site-directed mutagenesis to map functional domains of hbrm/BRG-1.
Main Results:
- RB can simultaneously bind E2F1 and hbrm/BRG-1, forming a ternary complex.
- RB and hbrm/BRG-1 cooperate to repress E2F1 activity in a manner dependent on specific hbrm/BRG-1 domains (RB binding, NTP binding).
- The bromodomain of hbrm/BRG-1 is dispensable for this repressive function.
Conclusions:
- hbrm/BRG-1 acts as a corepressor for E2F1 in conjunction with RB.
- This cooperation underlies the observed G1 arrest induced by RB and hbrm/BRG-1.
- RB not only targets hbrm/BRG-1 but also represses its transcriptional activation potential.
Related Concept Videos
Negative Regulator Molecules
RNA Polymerase II Accessory Proteins
Co-activators and Co-repressors
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Co-activators and Co-repressors
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...

